medical centers in federalresearch funding

"This patent represents an important milestone in developing the company'sintellectual property portfolio," said Rand Henke, CEO of LighthouseBiosciences."It addresses a breakthrough method that will allow the companyto design and make at a low cost a very wide range of probes for the detectionof most pathogens." The company is in the process of developing a prototype that consists of aseries of disposable biosensor cartridges or labs on a chip that will behoused in a workstation that can be deployed in hospitals, doctor's offices,nursing homes, or any other health care setting.While the technology has a wide array of potential applications in healthcare,agriculture, food safety, water quality, and national security, LighthouseBiosciences is initially focused on the field of hospital-acquired infections(HAI).HAI are infections that patients receive during their care in ahospital or other health care facility such as a nursing home that are notrelated to any pre-existing medical condition.Despite extensive efforts inrecent years to address the causes, HAI remain a massive burden on the U.S.health care system with more than 1 million annual cases and 90,000 associateddeaths, all at a healthcare cost of $5.7 billion per year and at a cost tosociety of approximately $30 billion per year in the U.S. Thecurrent standard is to send potentially infectious samples out to a clinicallaboratory for analysis and wait for the results. The NanoLantern technology hasdemonstrated the ability to provide results rapidly within 15 minutes and do so at the point of care.The largest category of HAIs is urinary tract infections, which account for40 of all infections. Lighthouse Biosciences, in cooperation with the URMCDepartments of Urology and Microbiology and Immunology is currently conductingclinical studies to test the screening system at URMC's Strong MemorialHospital.The underlying technology for the company's NanoLantern(TM) platform was firstdeveloped by University of Rochester scientists Benjamin Miller, Ph.D., ToddKrauss, Ph.D. About the University of Rochester Medical CenterOne of the nation's top academic medical centers, the University of RochesterMedical Center ( http://) forms the centerpiece of theUniversity's health research, teaching, patient care, and community outreachmissions.The Medical Center receives more than $230 million in externalresearch funding per year, and the University of Rochester School of Medicineand Dentistry ranks in the top one-quarter of U.S. medical centers in federalresearch funding.The University's health care delivery network is anchoredby Strong Memorial Hospital - a 739-bed, University-owned teaching hospital.

As upstate New York's premier health care delivery network, patients benefitfrom the Medical Center's robust teaching and biomedical research programs.About Lighthouse Biosciences, LLC Lighthouse Biosciences, LLC is an early-stage, molecular in vitro diagnosticcompany located in Rochester, NY.Based on its proprietary NanoLantern(TM)platform, Lighthouse is developing breakthrough diagnostic solutions that aremuch faster, more accurate, simpler, and less expensive than currently useddiagnostics. Additionally, the NanoLantern(TM) technology enables multipletests on a single sample for simultaneous and very reliable results.Lighthouse solutions consist of "lab on chip" disposable cartridges thatcontain highly targeted detection probes and sample chemistry and a desktopreader workstation for preparing and presenting test results.Lighthouseexpects its product solutions are small and simple enough to deploy throughoutdecentralized environments, like point-of-care healthcare locations, and arescalable to serve the high-volume needs of centralized laboratories. SOURCEUniversity of Rochester Medical CenterMark Michaud of University of Rochester Medical Center, 1-585-273-4790,. Dextrys CEO Brian Keane to Deliver Closing Keynote at Worldsourcing 2009ConferenceKeane to cite global collaboration as the key to success in today's evolvingbusiness climateWAKEFIELD, Mass., Jan.

8 /PRNewswire/ Dextrys, a premierUS-based China outsourcing firm delivering Product Engineering and ApplicationServices, today announced that its CEO Brian Keane has been selected todeliver the closing keynote address at Balanced Viewpoint's Worldsourcing 2009conference. The event will take place on January 12, 2009 at the NeptuneTheater in Halifax, Nova Scotia.Mr. Keane's remarks will highlight the importance of establishing globalpartnerships to effectively source business and technology solutions criticalto maintaining success in tumultuous economic conditions.Specifically, Mr.Keane will link innovation and continued growth to a sound "worldsourcing"strategy.Mr. Keane will also articulate why individuals in leadership rolesmust endorse the strategic value of global sourcing and ultimately drivesourcing decision-making."I'm honored to have been selected as a keynote speaker at this year'sWorldsourcing Conference," said Brian Keane, CEO of Dextrys. "At Dextrys, wecontinually strive to deliver tangible business value to our clients bytailoring flexible and cost-effective global delivery solutions leveraging theadvantages of China.I'm looking forward to sharing some of the bestpractices my team and I have gained through decades of global deliveryexperience, and I'm eager to learn about the first-hand experiences of otherrecognized executives on the conference agenda."Additional executives scheduled to speak at Worldsourcing 2009 include:Suhas Bhide, Partner & Vice President, Global Delivery, GlobalBusiness Services, IBM IndiaBruce Wallace, Leader, Healthcare Solutions, Enterprise BusinessSolutions, NortelHal Ryckman, Vice President and Strategic Sales Leader, EDS, an HPCompanyGreg Gulyas, Vice President, Global Services, IBMSebastien Ruest, Vice President, Services Research, IDCAbout DextrysDextrys is a US-based Chinese outsourcer providing Product Engineering andApplication Services globally.With more than 1400 employees acrossCalifornia, Boston, New York, Atlanta, Shanghai, Beijing, and Suzhou, China,Dextrys combines more than 20 years of US technology delivery experience withworld class engineering centers in China.Dextrys helps customers accelerateprofitable growth through cost effective, low risk services that improve thespeed, quality and responsiveness of their software development and qualityassurance organizations.Dextrys specializes in "Making China Easy" forcustomers, enabling them to capitalize on the cost, skill and businessopportunities available within one of the world's largest and fastest growingmarkets.For more information, visit http:// Milonas of Dextrys, 1-781-213-7868, ; or Media,Danielle Wuschke of Fleishman - Hillard, 1-617-692-0509,, for Dextrys. John Kemp is a Reuters columnist. They have also been the source of most of the marginal demand for crude oil, refined products and other raw materials.

Its modern export-oriented factories, many organized as joint ventures with foreign companies, have given it some of the fastest growth rates in China.Guangdong has consistently outperformed traditional industrial centers in the north-east around Heilongjiang, Jilin, Liaoning and Shandong. Central government leaders have urged the north-eastern provinces to follow the south's strategy: reform struggling industries focused on producing industrial materials and low value items for the domestic market, and re-orient them toward producing lighter, higher-value industrial products for export.But the reliance on exports that powered Guangdong's transformation over the last decade and made it the new "workshop of the world" have left it more vulnerable than any other of China's regions to the global slump.According to deputy governor Huang, Guangdong's output growth has already fallen from 14.7 percent in 2007 to just 10.1 percent in 2008. It could tumble as low as 7 percent this year, according to an economist with the province's Academy of Social Sciences, less than half the thirty-year average. If this is confirmed, it would reverse the traditional pattern of growth and social development that has characterized China since the country began to open up in the early 1980s.A VICTIM OF ITS SUCCESSIn some ways, Guangdong has fallen victim to its own success.